These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 31787695)

  • 41. Influenza Vaccine Effectiveness Against Hospitalization in the United States, 2019-2020.
    Tenforde MW; Talbot HK; Trabue CH; Gaglani M; McNeal TM; Monto AS; Martin ET; Zimmerman RK; Silveira FP; Middleton DB; Olson SM; Garten Kondor RJ; Barnes JR; Ferdinands JM; Patel MM;
    J Infect Dis; 2021 Sep; 224(5):813-820. PubMed ID: 33378531
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effectiveness of seasonal influenza vaccine for adults and children in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2015/16 end-of-season results.
    Pebody R; Warburton F; Ellis J; Andrews N; Potts A; Cottrell S; Johnston J; Reynolds A; Gunson R; Thompson C; Galiano M; Robertson C; Byford R; Gallagher N; Sinnathamby M; Yonova I; Pathirannehelage S; Donati M; Moore C; de Lusignan S; McMenamin J; Zambon M
    Euro Surveill; 2016 Sep; 21(38):. PubMed ID: 27684603
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Influenza vaccine effectiveness against medically attended influenza illness in Beijing, China, 2014/15 season.
    Ma C; Pan Y; Zhang L; Zhang Y; Wu S; Sun Y; Duan W; Zhang M; Wang Q; Yang P
    Hum Vaccin Immunother; 2017 Oct; 13(10):2379-2384. PubMed ID: 28846480
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season.
    Belongia EA; Kieke BA; Donahue JG; Greenlee RT; Balish A; Foust A; Lindstrom S; Shay DK;
    J Infect Dis; 2009 Jan; 199(2):159-67. PubMed ID: 19086915
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Influenza vaccine effectiveness against influenza-related hospitalization during a season with mixed outbreaks of four influenza viruses: a test-negative case-control study in adults in Canada.
    Andrew MK; Shinde V; Hatchette T; Ambrose A; Boivin G; Bowie W; Chit A; Dos Santos G; ElSherif M; Green K; Haguinet F; Halperin SA; Ibarguchi B; Johnstone J; Katz K; Langley JM; LeBlanc J; Loeb M; MacKinnon-Cameron D; McCarthy A; McElhaney J; McGeer A; Nichols MK; Powis J; Richardson D; Semret M; Stiver G; Trottier S; Valiquette L; Webster D; Ye L; McNeil SA;
    BMC Infect Dis; 2017 Dec; 17(1):805. PubMed ID: 29284435
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inactivated influenza vaccine effectiveness among department of defense beneficiaries aged 6 months-17 years, 2016-2017 through 2019-2020 influenza seasons.
    Hu W; DeMarcus LS; Sjoberg PA; Robbins AS
    PLoS One; 2021; 16(8):e0256165. PubMed ID: 34450617
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Protection provided by influenza vaccine against influenza-related hospitalisation in ≥65 year olds: Early experience of introduction of a newly licensed adjuvanted vaccine in England in 2018/19.
    Pebody R; Whitaker H; Zhao H; Andrews N; Ellis J; Donati M; Zambon M
    Vaccine; 2020 Jan; 38(2):173-179. PubMed ID: 31653528
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Vaccine effectiveness against influenza hospitalisation in adults during the 2022/2023 mixed season of influenza A(H1N1)pdm09, A(H3N2) and B circulation, Europe: VEBIS SARI VE hospital network.
    Rose AMC; Pozo F; Martínez-Baz I; Mazagatos C; Bossuyt N; Cauchi JP; Petrović G; Loghin II; Vaikutyte R; Buda S; Machado A; Duffy R; Oroszi B; Howard J; Echeverria A; Andreu C; Barbezange C; Džiugytė A; Nonković D; Popescu CP; Majauskaite F; Tolksdorf K; Gomez V; Domegan L; Horváth JK; Castilla J; García M; Demuyser T; Borg ML; Tabain I; Lazar M; Kubiliute I; Dürrwald R; Guiomar R; O'Donnell J; Kristóf K; Nicolay N; Bacci S; Kissling E; ;
    Influenza Other Respir Viruses; 2024 Feb; 18(2):e13255. PubMed ID: 38403302
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of previous and current vaccination against influenza A(H1N1)pdm09, A(H3N2), and B during the post-pandemic period 2010-2016 in Spain.
    Gherasim A; Martínez-Baz I; Castilla J; Pozo F; Larrauri A;
    PLoS One; 2017; 12(6):e0179160. PubMed ID: 28614376
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Low influenza vaccine effectiveness and the effect of previous vaccination in preventing admission with A(H1N1)pdm09 or B/Victoria-Lineage in patients 60 years old or older during the 2015/2016 influenza season.
    Puig-Barberà J; Guglieri-López B; Tortajada-Girbés M; López-Labrador FX; Carballido-Fernández M; Mollar-Maseres J; Schwarz-Chavarri G; Baselga-Moreno V; Mira-Iglesias A; Díez-Domingo J;
    Vaccine; 2017 Dec; 35(52):7331-7338. PubMed ID: 29128380
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Influenza epidemiology, vaccine coverage and vaccine effectiveness in children admitted to sentinel Australian hospitals in 2014: the Influenza Complications Alert Network (FluCAN).
    Blyth CC; Macartney KK; Hewagama S; Senenayake S; Friedman ND; Simpson G; Upham J; Kotsimbos T; Kelly P; Cheng AC
    Euro Surveill; 2016 Jul; 21(30):. PubMed ID: 27494798
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Interim Estimates of 2021-22 Seasonal Influenza Vaccine Effectiveness - United States, February 2022.
    Chung JR; Kim SS; Kondor RJ; Smith C; Budd AP; Tartof SY; Florea A; Talbot HK; Grijalva CG; Wernli KJ; Phillips CH; Monto AS; Martin ET; Belongia EA; McLean HQ; Gaglani M; Reis M; Geffel KM; Nowalk MP; DaSilva J; Keong LM; Stark TJ; Barnes JR; Wentworth DE; Brammer L; Burns E; Fry AM; Patel MM; Flannery B
    MMWR Morb Mortal Wkly Rep; 2022 Mar; 71(10):365-370. PubMed ID: 35271561
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Substantial Influenza Vaccine Effectiveness in Households With Children During the 2013-2014 Influenza Season, When 2009 Pandemic Influenza A(H1N1) Virus Predominated.
    Ohmit SE; Petrie JG; Malosh RE; Johnson E; Truscon R; Aaron B; Martens C; Cheng C; Fry AM; Monto AS
    J Infect Dis; 2016 Apr; 213(8):1229-36. PubMed ID: 26597255
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies.
    Belongia EA; Simpson MD; King JP; Sundaram ME; Kelley NS; Osterholm MT; McLean HQ
    Lancet Infect Dis; 2016 Aug; 16(8):942-51. PubMed ID: 27061888
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Influenza vaccine effectiveness estimates against influenza A(H3N2) and A(H1N1) pdm09 among children during school-based outbreaks in the 2016-2017 season in Beijing, China.
    Zhang L; van der Hoek W; Krafft T; Pilot E; Asten LV; Lin G; Wu S; Duan W; Yang P; Wang Q
    Hum Vaccin Immunother; 2020 Apr; 16(4):816-822. PubMed ID: 31596661
    [No Abstract]   [Full Text] [Related]  

  • 56. Interim 2019/20 influenza vaccine effectiveness: six European studies, September 2019 to January 2020.
    Rose A; Kissling E; Emborg HD; Larrauri A; McMenamin J; Pozo F; Trebbien R; Mazagatos C; Whitaker H; Valenciano M;
    Euro Surveill; 2020 Mar; 25(10):. PubMed ID: 32183932
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Vaccine Effectiveness Against Pediatric Influenza Hospitalizations and Emergency Visits.
    Campbell AP; Ogokeh C; Lively JY; Staat MA; Selvarangan R; Halasa NB; Englund JA; Boom JA; Weinberg GA; Williams JV; McNeal M; Harrison CJ; Stewart LS; Klein EJ; Sahni LC; Szilagyi PG; Michaels MG; Hickey RW; Moffat ME; Pahud BA; Schuster JE; Weddle GM; Rha B; Fry AM; Patel M
    Pediatrics; 2020 Nov; 146(5):. PubMed ID: 33020249
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Late-Season Influenza Vaccine Effectiveness Against Medically Attended Outpatient Illness, United States, December 2022-April 2023.
    Chung JR; Shirk P; Gaglani M; Mutnal MB; Nowalk MP; Moehling Geffel K; House SL; Curley T; Wernli KJ; Kiniry EL; Martin ET; Vaughn IA; Murugan V; Lim ES; Saade E; Faryar K; Williams OL; Walter EB; Price AM; Barnes JR; DaSilva J; Kondor R; Ellington S; Flannery B
    Influenza Other Respir Viruses; 2024 Jun; 18(6):e13342. PubMed ID: 38923314
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Influenza vaccine effectiveness against medically-attended influenza illness during the 2012-2013 season in Beijing, China.
    Yang P; Thompson MG; Ma C; Shi W; Wu S; Zhang D; Wang Q
    Vaccine; 2014 Sep; 32(41):5285-9. PubMed ID: 25092635
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Influenza vaccine effectiveness in preventing inpatient and outpatient cases in a season dominated by vaccine-matched influenza B virus.
    Martínez-Baz I; Navascués A; Pozo F; Chamorro J; Albeniz E; Casado I; Reina G; Cenoz MG; Ezpeleta C; Castilla J;
    Hum Vaccin Immunother; 2015; 11(7):1626-33. PubMed ID: 25996366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.